SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, C ...

NEW YORK, April 29, 2025 /PRNewswire/ -- S&P Dow Jones Indices (S&P DJI) today released the February 2025 results for the S&P CoreLogic Case-Shiller Indices. The leading measure of U.S. home prices recorded a 3.9% annual gain in February 2025, a slight decrease from the previous reading in January 2025. More than 27 years of history are available for the data series and can be accessed in full by going to https://www.spglobal.com/spdji/en/index-family/indicators/sp-corelogic-case-shiller/.YEAR-OVER-YEARThe ...

— Accelerated recurring organic revenue growth —— Reaffirmed 2025 Outlook —— Repurchased $50 million ordinary shares —LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025.Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first ...

Delphine Dirat LSEG 政府关系与监管战略高级经理 Elena Philipova LSEG 可持续发展金融总监 David Harris LSEG 可持续发展金融总监 欧洲委员会已公布针对其可持续发展金融议程关键要素的全面改革方案，以简化欧盟的各项要求并提升欧洲 的竞争力。委员会提出的综合方案提议大幅减少受披露规则约束的公司数量，并力求简化与该披露相关的技 术性要求。 尽管报告中的削减方案以及聚焦于更具实质性数据的提案已得到广泛支持，但综合方案中的豁免条款也使投 资者可获取的企业可持续性信息的数量和全面性有所降低。 我们一直密切关注相关进展，并与监管机构及其他利益相关方保持紧密合作，以确保金融专业人士能够获取 所需数据，从而更有效地管理风险并履行监管报告义务。我们最近提出了一系列改革建议，并正在组织讨 论。接下来， 我们将深入探讨这些提案对投资者和发行人的影响，以及LSEG是如何帮助他们应对这些变化 所带来的不确定性。 综合提案背景 近年来，欧盟的可持续发展金融战略已推出多项举措，旨在引导资本投向欧盟所设定的环境目标。这些举措 包括： 欧盟分类法（EU Taxonomy） 该分类法明确了哪些 ...

Financial Data and Key Metrics Changes - In Q2 2025, organic ASV grew by 4.1% year-over-year, with an adjusted operating margin of 37.3% and adjusted diluted EPS of $4.28 [9][10][43] - GAAP revenues increased by 4.5% year-over-year to $571 million, while organic revenues grew by 4% to $568 million [35][36] - Free cash flow was $150 million in Q2, up 23% over the same period last year [44] Business Line Data and Key Metrics Changes - Wealth management saw double-digit growth, with significant wins including a contract with UBS [15][16] - The banking segment faced challenges, but renewal activity increased, with over a dozen large banking renewals signed [18][20] - PEVC experienced accelerated double-digit growth, while asset management faced headwinds due to cost rationalization [21][22] Market Data and Key Metrics Changes - In the Americas, organic ASV grew by 4%, while EMEA saw 3% growth and Asia-Pacific maintained 7% growth [12][13][14] - The wealth segment is gaining market share, particularly in the Americas, with expansion opportunities in Europe and Asia [16][17][118] Company Strategy and Development Direction - The company is focused on driving top-line growth, with a strong sales pipeline and product-led innovation [25][26] - Recent acquisitions, including LiquidityBook, are expected to enhance service offerings and cross-sell opportunities [23][27][111] - The strategy includes expanding into new regions and adding services to existing clients, particularly in wealth management [119] Management's Comments on Operating Environment and Future Outlook - Management acknowledges a challenging market environment but expresses confidence in the sales pipeline and product innovation [10][11] - There is optimism about growth acceleration in the second half of the fiscal year, with reaffirmed guidance for organic ASV growth [47][50] - The company is well-positioned to capitalize on Gen AI products and improve client engagement [31][50] Other Important Information - The company repurchased nearly 137,000 shares for approximately $64 million during the quarter [45] - The effective tax rate for Q2 was 15.9%, a decrease from the previous year [42] - The company is committed to returning capital to shareholders while maintaining investment-grade ratings [46][47] Q&A Session Summary Question: Can you provide more details on the traction with Gen AI products? - Management reported strong momentum with PitchCreator and other Gen AI products, with positive client reception and active trials [56][62] Question: Is the environment improving or is the company performing better in a challenging market? - Management believes they have de-risked major challenges and are seeing strength across all markets, with a positive outlook for the second half [68][71] Question: How does banking factor into the guidance range? - Management indicated that they are not relying on banking for their numbers, with conservative estimates baked into the guidance [76][80] Question: Is the UBS Vault deal included in ASV this quarter? - Yes, the UBS deal was signed in the quarter, but the ASV impact will be realized in the following quarters [84][87] Question: What is the pricing outlook given the lower CPI? - Management expects international pricing to align with the lower CPI, impacting annual price increases [90][92] Question: How are technology costs impacting margins? - Management is actively managing technology and people costs, with expectations of a ramp-up in expenses for strategic investments in the second half [96][100]

FactSet (FDS) Q2 2025 Earnings Call March 20, 2025 09:00 AM ET Company Participants Yet He - Global Head of FP&A and TreasurerPhilip Snow - CEOHelen Shan - Executive VP & CFOGoran Skoko - EVP, Chief Revenue OfficerShlomo Rosenbaum - Managing DirectorAlex Kramm - Managing Director - Equity ResearchFaiza Alwy - Managing Director, US Company ResearchBrendan Popson - Vice President - Business, Information & Professional Services Equity ResearchRyan Griffin - Senior Equity Research Associate Conference Call Part ...